Literature DB >> 28736060

Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes.

Kevin Anderson1, Ewa Ruel2, Mohamed A Adam3, Samantha Thomas4, Linda Youngwirth3, Michael T Stang5, Randall P Scheri6, Sanziana A Roman6, Julie A Sosa7.   

Abstract

BACKGROUND: The optimal surgery for patients with renal hyperparathyroidism has been controversial, as either subtotal parathyroidectomy (subtotal PTX) or total parathyroidectomy with auto-transplantation (total PTX-AT) may be employed.
METHODS: Adult patients having subtotal PTX or total PTX-AT for secondary hyperparathyroidism were identified from the American College of Surgeons National Surgical Quality Improvement Program, 2005-2013.
RESULTS: Of 1130 patients, the majority (n = 765, 68%) underwent subtotal PTX. Total PTX-AT was associated with longer operative time (median 150 vs. 120 min, p < 0.001). Rates of complications, reoperation, readmission, and 30-day mortality were not significantly different. After adjustment, the odds of having a complication [OR 0.97, p = 0.88] and being readmitted within 30 days [OR 0.86 p = 0.62] were similar between the two procedures. Total PTX-AT was associated with prolonged hospital stay [Adjusted mean 5.0 vs. 4.1 days; (RR) 1.22, p < 0.001] compared to subtotal PTX.
CONCLUSIONS: Subtotal PTX and total PTX-AT have similar rates of complications, readmission, and 30-day mortality, but subtotal PTX is less likely to have extended hospital stay. These findings have important cost implications for patients, payers, and hospitals.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hyperparathyroidism; Parathyroidectomy; Surgical outcomes

Mesh:

Year:  2017        PMID: 28736060     DOI: 10.1016/j.amjsurg.2017.07.018

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

Review 1.  Parathyroidectomy in the Management of Secondary Hyperparathyroidism.

Authors:  Wei Ling Lau; Yoshitsugu Obi; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-09       Impact factor: 8.237

2.  Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis.

Authors:  Qianqian Yuan; Yiqin Liao; Rui Zhou; Jiuyang Liu; Jianing Tang; Gaosong Wu
Journal:  Langenbecks Arch Surg       Date:  2019-08-03       Impact factor: 3.445

3.  Risk Factors for Readmission After Parathyroidectomy for Renal Hyperparathyroidism.

Authors:  Justin D Lee; Eric J Kuo; Lin Du; Michael W Yeh; Masha J Livhits
Journal:  World J Surg       Date:  2019-02       Impact factor: 3.352

4.  Parathyromatosis type 2 detected by 99mTc-MIBI SPECT/CT.

Authors:  Huixiao Cao; Ming Zeng; Haisheng Fang; Lijun Tang; Wei Liu
Journal:  Gland Surg       Date:  2019-12

5.  How radical is total parathyroidectomy in patients with renal hyperparathyroidism?

Authors:  Thomas Burgstaller; Andreas Selberherr; Lindsay Brammen; Christian Scheuba; Klaus Kaczirek; Philipp Riss
Journal:  Langenbecks Arch Surg       Date:  2018-12-05       Impact factor: 3.445

Review 6.  Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives.

Authors:  Bala Waziri; Raquel Duarte; Saraladevi Naicker
Journal:  Int J Nephrol Renovasc Dis       Date:  2019-12-24

Review 7.  A roadmap to parathyroidectomy for kidney transplant candidates.

Authors:  Giuseppe Cianciolo; Francesco Tondolo; Simona Barbuto; Andrea Angelini; Francesca Ferrara; Francesca Iacovella; Concettina Raimondi; Gaetano La Manna; Carla Serra; Chiara De Molo; Ottavio Cavicchi; Ottavio Piccin; Pasquale D'Alessio; Loredana De Pasquale; Giovanni Felisati; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  Clin Kidney J       Date:  2022-02-23

8.  Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.

Authors:  Manuela Capozza; Iolanda Chinellato; Vito Guarnieri; Natascia Di Lorgi; Maria Accadia; Cristina Traggiai; Girolamo Mattioli; Antonio Di Mauro; Nicola Laforgia
Journal:  BMC Pediatr       Date:  2018-10-30       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.